December 16, 2020
The United States has a population of approximately 330 million people and assured this Wednesday that it has already contracted 900 million doses of the vaccine against Covid-19 and would receive up to 3,000 million, which would guarantee “surpluses” that it plans to share with other countries of the world.
“Right now we have 900 million doses of the vaccine contracted for delivery to us, and we have options that increase that to a total of 3 billion doses,” said US Secretary of Health Alex Azar in a Press conference.
“We believe that, in fact, we will have surpluses in our vaccine supply, and that is why President Trump signed an executive order committing to take those surpluses, of vaccines and manufacturing capacity, and we would use them for the benefit of the world community,” he added.
The US is not part of the COVAX platform promoted by the World Health Organization (WHO) to guarantee global access and on equal terms to vaccines. and it has been negotiating with Pfizer another 100 million doses that would help the laboratory to produce in the first half of 2021.
“We are working with Pfizer and I am very optimistic that we will be successful,” Azar said.
According to Azar, the Trump administration has offered Pfizer “full support to ensure that they can produce” more doses of vaccines since the laboratory has “recently reported several challenges that they could have in their manufacturing process.”
In addition to the 100 million guaranteed doses from Pfizer, the United States has acquired another 200 million from Moderna, and 300 million from the vaccine in development from AstraZeneca, 100 million from Novavax, 100 million from Sanofi and GSK and another 100 from Johnson and Johnson.